https://www.selleckchem.com/pr....oducts/5-n-ethylcarb
QOL data were available for 15 patients at the 6-month follow-up, showing a good profile of general and disease-specific QOL. REPLICA offered a safe solution at 1-year for the treatment of mandibular defects not suitable for reconstruction with traditional techniques, and was associated with subjective well-being and satisfaction. Further studies are needed to assess the full range of indications of REPLICA. REPLICA offered a safe solution at 1-year for the treatment of mandibular defects not suitable for reconstru
כמו
תגובה
לַחֲלוֹק
